Penserra Capital Management LLC Homology Medicines, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$3.64 - $7.78 $4,750 - $10,152	-1,305 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.01 - $8.71 $30 - $43	5 Added 0.38%	1,305 $10,000
Q2 2021 Aug 12, 2021	BUY	$6.02 - $9.64 $1,655 - $2,651	275 Added 26.83%	1,300 $9,000
Q1 2021 May 13, 2021	SELL	$9.17 - $14.8 $137 - $222	-15 Reduced 1.44%	1,025 $9,000
Q4 2020 Feb 12, 2021	BUY	$8.92 - $13.29 $5,833 - $8,691	654 Added 169.43%	1,040 $11,000

Q3 2020 Nov 13, 2020	BUY	$9.94 - $16.59 $3,836 - $6,403	386 New	386 $4,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.